Emergent BioSolutions Inc (EBS)
1.87
-0.03
(-1.58%)
USD |
NYSE |
Apr 18, 16:00
1.88
+0.01
(+0.53%)
After-Hours: 20:00
Emergent BioSolutions Revenue (TTM): 1.024B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.024B |
| September 30, 2023 | 1.077B |
| June 30, 2023 | 1.036B |
| March 31, 2023 | 939.60M |
| December 31, 2022 | 1.079B |
| September 30, 2022 | 1.389B |
| June 30, 2022 | 1.479B |
| March 31, 2022 | 1.616B |
| December 31, 2021 | 1.639B |
| September 30, 2021 | 1.568B |
| June 30, 2021 | 1.615B |
| March 31, 2021 | 1.614B |
| December 31, 2020 | 1.462B |
| September 30, 2020 | 1.236B |
| June 30, 2020 | 1.153B |
| March 31, 2020 | 984.50M |
| December 31, 2019 | 983.50M |
| September 30, 2019 | 891.60M |
| June 30, 2019 | 770.80M |
| March 31, 2019 | 772.30M |
| December 31, 2018 | 705.30M |
| September 30, 2018 | 638.82M |
| June 30, 2018 | 616.63M |
| March 31, 2018 | 492.70M |
| December 31, 2017 | 490.40M |
| Date | Value |
|---|---|
| September 30, 2017 | 416.74M |
| June 30, 2017 | 394.94M |
| March 31, 2017 | 373.66M |
| December 31, 2016 | 345.40M |
| September 30, 2016 | 376.17M |
| June 30, 2016 | 393.61M |
| March 31, 2016 | 426.01M |
| December 31, 2015 | 385.20M |
| September 30, 2015 | 343.22M |
| June 30, 2015 | 308.26M |
| March 31, 2015 | 304.83M |
| December 31, 2014 | 312.79M |
| September 30, 2014 | 305.51M |
| June 30, 2014 | 287.92M |
| March 31, 2014 | 266.06M |
| December 31, 2013 | 257.92M |
| September 30, 2013 | 246.60M |
| June 30, 2013 | 224.32M |
| March 31, 2013 | 211.88M |
| December 31, 2012 | 215.88M |
| September 30, 2012 | 178.50M |
| June 30, 2012 | 183.25M |
| March 31, 2012 | 218.23M |
| December 31, 2011 | 202.41M |
| September 30, 2011 | 233.89M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
770.80M
Minimum
Jun 2019
1.639B
Maximum
Dec 2021
1.240B
Average
1.153B
Median
Jun 2020
Revenue (TTM) Benchmarks
| Avid Bioservices Inc | 140.94M |
| Viking Therapeutics Inc | -- |
| FibroGen Inc | 147.75M |
| Avinger Inc | 7.652M |
| RAPT Therapeutics Inc | -- |